Gemopatrilat

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameGemopatrilat
Drug Alias Name吉莫曲拉gemopatrilat格帕曲拉gemopatrilatumBMS-189921
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin-converting enzyme inhibitorsNeprilysin inhibitors
TargetsAngiotensin-converting enzymeNeprilysin
Therapy Area/IndicationsHypertensionHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHypertensionHeart Failure

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG